- The impact on market access for Israeli businesses, from taxation to capital raises, regulatory controls, white collar investigations, and other key issues of concern to Israeli companies;
- Deciphering the election results at the White House and in Congress;
- The U.S.-China-lsrael dynamic;
- The Committee on Foreign Investment in the United States (CFIUS);
- U.S. security assistance to Israel, supply chain, and export and controls;
- Life sciences, digital health, COVID-19, and the Food & Drug Administration (FDA); and
- U.S.-Middle East policies: normalizations, the Palestinian-Israeli conflict, and Iran.
Have a question on this topic? We are here to help
Every case is unique. Let's talk about yours.


